Hogne Vik, MD, PhD, MBA, is chief medical officer (CMO) with NattoPharma (now Gnosis by Lesaffre). Educated as a physician and researcher at Haukeland University Hospital, Bergen, Norway, he specialized in clinical laboratory medicine and immunology/ allergy. He was thereafter working in clinical medicine, as a physician, researcher, and lecturer as Professor II. Dr Vik is an author of more than 100 original pre-reviewed scientific, medical publications, and was involved in establishment of NattoPharma ASA in 2004. He was chairman of the board in the company when it was listed at Oslo Stock exchange in 2008, was CEO in the company in the period 2012 to 2016, and then stepped into the position as the company´s medical spokesperson and CMO.
Hogne’s Recent activity
Research around vitamin K2 and its importance in cardiovascular health underscores the importance of setting an RDI for K2.
The relationship between K2 and fractures in children was recently investigated with a new study showing the increased risk of fracture in children with low vitamin K2 status.